|
Schwarcz, Robert; Guidetti, Paolo; Sathyasaikumar, Korrapati V et al. (2010) Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease. Prog Neurobiol 90:230-45
|
|
Guidetti, P; Charles, V; Chen, E Y et al. (2001) Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production. Exp Neurol 169:340-50
|
|
Lehrmann, E; Molinari, A; Speciale, C et al. (2001) Immunohistochemical visualization of newly formed quinolinate in the normal and excitotoxically lesioned rat striatum. Exp Brain Res 141:389-97
|
|
Guidetti, P; Reddy, P H; Tagle, D A et al. (2000) Early kynurenergic impairment in Huntington's disease and in a transgenic animal model. Neurosci Lett 283:233-5
|
|
Wu, H Q; Lee, S C; Schwarcz, R (2000) Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus. Eur J Pharmacol 390:267-74
|
|
Battaglia, G; Rassoulpour, A; Wu, H Q et al. (2000) Some metabotropic glutamate receptor ligands reduce kynurenate synthesis in rats by intracellular inhibition of kynurenine aminotransferase II. J Neurochem 75:2051-60
|
|
Guidetti, P; Wu, H Q; Schwarcz, R (2000) In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum. Exp Neurol 163:123-30
|
|
Poeggeler, B; Pappolla, M A; Hardeland, R et al. (1999) Indole-3-propionate: a potent hydroxyl radical scavenger in rat brain. Brain Res 815:382-8
|
|
Guidetti, P; Schwarcz, R (1999) 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum. Eur J Neurosci 11:3857-63
|
|
Hodgkins, P S; Wu, H Q; Zielke, H R et al. (1999) 2-Oxoacids regulate kynurenic acid production in the rat brain: studies in vitro and in vivo. J Neurochem 72:643-51
|
Showing the most recent 10 out of 58 publications
